Ginseng

178 research sources Also known as: panax ginseng asian ginseng korean ginseng red ginseng
481 Products on Market
450.0 mg Median Dose
🟢 90/100 Market Safety Score
178 Research Sources
Browse 481 products →

Top-Rated Ginseng Products

View all Ginseng products → Best Ginseng rankings →

Evidence Summary

Ginseng is a widely researched supplement with a large body of evidence, primarily focused on its effects on physical performance, fatigue, and metabolic health. Meta-analyses suggest potential benefits for athletic ergogenic effects, fatigue reduction, and the management of certain cardiovascular and respiratory conditions.

Evidence by Condition

Ginseng supplements are effective in improving physical performance and reducing both general and disease-related fatigue.

Cochrane reviews have investigated the efficacy of ginseng for cognitive enhancement.

Ginseng-related therapies have shown efficacy in the management of Type 2 Diabetes Mellitus.

Evidence indicates that ginseng supplementation may influence plasma lipid concentrations and various CVD risk factors.

Panax notoginseng saponins have shown clinical efficacy in treating COPD associated with blood hypercoagulability.

Effective Doses

Dose ranges were not explicitly provided in the source text.

Key Findings

  • Ginseng supplements are effective for improving physical performance and reducing fatigue (PMID: 27822924).
  • Ginseng supplementation may influence plasma lipid concentrations in adults (PMID: 31987252).
  • Panax notoginseng saponins show clinical efficacy in treating COPD with blood hypercoagulability (PMID: 38216446).
  • Ginseng-related therapies have demonstrated efficacy in Type 2 Diabetes Mellitus (PMID: 26871778).

Limitations

Much of the high-quality evidence focuses on specific derivatives, such as Panax notoginseng saponins, or specific populations like athletes, which may limit generalizability.

Safety & Interactions

No specific drug interactions or contraindications were detailed in the provided research summaries.

AI-generated summary from 178 peer-reviewed studies. Not medical advice. Always consult a healthcare provider.

Drug-Supplement Interactions

Antiarrhythmics 🔴 Critical
Mechanism: Ginseng is a weak inhibitor of CYP2C9, which decreases metabolism of CYP2C9 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of amiodarone (antiarrhythmics), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of amiodarone. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
Anticonvulsants 🔴 Critical
Mechanism: Ginseng is a weak inhibitor of CYP3A4, which decreases metabolism of CYP3A4 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of carbamazepine (anticonvulsants), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of carbamazepine. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
GI Prokinetics 🔴 Critical
Mechanism: Ginseng is a weak inhibitor of CYP3A4, which decreases metabolism of CYP3A4 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of cisapride (gi-prokinetics), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of cisapride. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
Immunosuppressants 🔴 Critical
Mechanism: Ginseng is a weak inhibitor of CYP3A4, which decreases metabolism of CYP3A4 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of cyclosporine (immunosuppressants), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of cyclosporine. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
Theophylline 🔴 Critical
Mechanism: Ginseng is a weak inhibitor of CYP3A4, which decreases metabolism of CYP3A4 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of theophylline (theophylline), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of theophylline. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
ADHD Medications 🟡 Moderate
Mechanism: Ginseng is a weak inhibitor of CYP2D6, which decreases metabolism of CYP2D6 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of atomoxetine (adhd-medications), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of atomoxetine. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
ARB 🟡 Moderate
Mechanism: Ginseng is a weak inhibitor of CYP2C9, which decreases metabolism of CYP2C9 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of losartan (arb), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of losartan. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
Abciximab 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Abciximab
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Acetohexamide 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Acetohexamide
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Albiglutide 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Albiglutide
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Alteplase 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Alteplase
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Anistreplase 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Anistreplase
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Antiandrogens 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Finasteride
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Antibiotics 🟡 Moderate
Mechanism: Ginseng is a weak inhibitor of CYP3A4, which decreases metabolism of CYP3A4 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of clarithromycin (antibiotics), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of clarithromycin. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
Anticoagulants 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Apixaban, Edoxaban, Rivaroxaban, Enoxaparin, Fondaparinux, Dicoumarol, Heparin
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Antidiabetic Drugs 🟡 Moderate
Mechanism: Ginseng may lower blood glucose, potentially additive with diabetes medications.
Effect: Possible additive hypoglycemic effect
Management: Monitor blood glucose closely. May need to reduce medication dose.
Evidence: possible
Antiemetics 🟡 Moderate
Mechanism: Ginseng is a weak inhibitor of CYP2D6, which decreases metabolism of CYP2D6 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of ondansetron (antiemetics), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of ondansetron. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
Antifungals 🟡 Moderate
Mechanism: Ginseng is a weak inhibitor of CYP3A4, which decreases metabolism of CYP3A4 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of fluconazole (antifungals), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of fluconazole. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
Antiplatelet Drugs 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Acetylsalicylic acid, Dipyridamole, Acetylsalicylic acid, Clopidogrel, Prasugrel, Ticagrelor, Ticlopidine, Vorapaxar
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Antipsychotics 🟡 Moderate
Mechanism: Ginseng is a weak inhibitor of CYP3A4, which decreases metabolism of CYP3A4 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of haloperidol (antipsychotics), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of haloperidol. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
Antithrombin III human 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Antithrombin III human
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Antitussives 🟡 Moderate
Mechanism: Ginseng is a weak inhibitor of CYP2D6, which decreases metabolism of CYP2D6 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of dextromethorphan (antitussives), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of dextromethorphan. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
Argatroban 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Argatroban
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Benzodiazepines 🟡 Moderate
Mechanism: Ginseng is a weak inhibitor of CYP3A4, which decreases metabolism of CYP3A4 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of midazolam (benzodiazepines), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of midazolam. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
Beta Blockers 🟡 Moderate
Mechanism: Ginseng is a weak inhibitor of CYP2D6, which decreases metabolism of CYP2D6 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of metoprolol (beta-blockers), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of metoprolol. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
Beta-2 Agonists 🟡 Moderate
Mechanism: Ginseng is a weak inhibitor of CYP3A4, which decreases metabolism of CYP3A4 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of salmeterol (beta2-agonists), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of salmeterol. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
Betrixaban 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Betrixaban
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Bivalirudin 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Bivalirudin
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
CFTR Modulators 🟡 Moderate
Mechanism: Ginseng is a weak inhibitor of CYP3A4, which decreases metabolism of CYP3A4 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of ivacaftor (cftr-modulators), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of ivacaftor. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
Calcium Channel Blockers 🟡 Moderate
Mechanism: Ginseng is a weak inhibitor of CYP3A4, which decreases metabolism of CYP3A4 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of nifedipine (calcium-channel-blockers), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of nifedipine. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
Cangrelor 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Cangrelor
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Caplacizumab 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Caplacizumab
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Chemotherapy 🟡 Moderate
Mechanism: Ginseng is a weak inhibitor of CYP3A4, which decreases metabolism of CYP3A4 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of doxorubicin (chemotherapy), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of doxorubicin. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
Corticosteroids 🟡 Moderate
Mechanism: Ginseng is a weak inhibitor of CYP3A4, which decreases metabolism of CYP3A4 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of prednisone (corticosteroids), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of prednisone. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
Dalteparin 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Dalteparin
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Danaparoid 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Danaparoid
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Defibrotide 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Defibrotide
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Eptifibatide 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Eptifibatide
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Ertugliflozin 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Ertugliflozin
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Insulin aspart (aspart protamine)
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Insulin aspart (aspart) 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Insulin aspart (aspart)
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Insulin degludec 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Insulin degludec
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Insulin detemir 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Insulin detemir
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Insulin glargine 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Insulin glargine
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Insulin glulisine 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Insulin glulisine
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Insulin human 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Insulin human
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Insulin human (inhalation, rapid acting)
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Insulin human (isophane) 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Insulin human (isophane)
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Insulin human (regular) 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Insulin human (regular)
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Insulin human (zinc extended)
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Insulin human (zinc) 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Insulin human (zinc)
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Insulin lispro 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Insulin lispro
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Insulin lispro (protamine)
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Lepirudin 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Lepirudin
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Leukotriene Antagonists 🟡 Moderate
Mechanism: Ginseng is a weak inhibitor of CYP3A4, which decreases metabolism of CYP3A4 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of montelukast (leukotriene-antagonists), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of montelukast. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
Lixisenatide 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Lixisenatide
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Miglitol 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Miglitol
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
NSAIDs 🟡 Moderate
Mechanism: Ginseng is a weak inhibitor of CYP2C9, which decreases metabolism of CYP2C9 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of ibuprofen (nsaids), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of ibuprofen. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
Opioids 🟡 Moderate
Mechanism: Ginseng is a weak inhibitor of CYP3A4, which decreases metabolism of CYP3A4 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of methadone (opioids), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of methadone. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
Oral Contraceptives 🟡 Moderate
Mechanism: Ginseng is a weak inhibitor of CYP3A4, which decreases metabolism of CYP3A4 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of ethinylestradiol (oral-contraceptives), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of ethinylestradiol. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
PDE5 Inhibitors 🟡 Moderate
Mechanism: Ginseng is a weak inhibitor of CYP3A4, which decreases metabolism of CYP3A4 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of sildenafil (pde5-inhibitors), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of sildenafil. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
PPIS 🟡 Moderate
Mechanism: Ginseng is a weak inhibitor of CYP3A4, which decreases metabolism of CYP3A4 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of omeprazole (ppis), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of omeprazole. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
Pramlintide 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Pramlintide
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Reteplase 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Reteplase
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
SNRI 🟡 Moderate
Mechanism: Ginseng is a weak inhibitor of CYP3A4, which decreases metabolism of CYP3A4 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of venlafaxine (snri), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of venlafaxine. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
Statins 🟡 Moderate
Mechanism: Ginseng is a weak inhibitor of CYP3A4, which decreases metabolism of CYP3A4 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of simvastatin (statins), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of simvastatin. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
Streptokinase 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Streptokinase
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Tenecteplase 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Tenecteplase
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Tinzaparin 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Tinzaparin
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Tirofiban 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Tirofiban
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Mechanism: Ginseng is a weak inhibitor of CYP3A4, which decreases metabolism of CYP3A4 substrates, potentially increasing their plasma concentrations and risk of adverse effects.
Effect: Increased plasma levels of amitriptyline (tricyclic-antidepressants), potentially leading to toxicity or enhanced adverse effects.
Management: Monitor for increased adverse effects of amitriptyline. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.
Evidence: cyp-inferred
Urokinase 🟡 Moderate
Mechanism: Interaction identified from DDInter 2.0 database. Specific drugs: Urokinase
Effect: See mechanism description
Management: Consult healthcare provider before combining.
Evidence: ddinter-verified
Warfarin 🟡 Moderate
Mechanism: Ginseng may reduce warfarin efficacy, possibly through CYP enzyme induction or ginsenoside effects on clotting.
Effect: Reduced anticoagulant effect; decreased INR
Management: Monitor INR closely. Avoid ginseng supplements if possible.
Evidence: probable
Ssri 🟢 Minor
Mechanism: Ginseng may have weak MAO-inhibiting properties; theoretical risk of serotonin syndrome with SSRIs.
Effect: Possible additive serotonergic effect (rare)
Management: Generally safe at typical doses. Report any agitation or confusion.
Evidence: possible
Stimulants 🟢 Minor
Mechanism: Ginseng has mild stimulant properties; combined with caffeine or other stimulants may cause overstimulation.
Effect: Possible insomnia, nervousness, tachycardia
Management: Moderate intake of both. Avoid high-dose combinations.
Evidence: possible

⚠️ This information is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider before combining supplements with medications.

Claims vs. Evidence

80% Evidence-Backed
20% Unsupported
82% Structure/Function
Claim Type% of ProductsEvidence RequiredStatus
All Other 98% Tier D (Unclassified) ✅ Supported
Structure/Function 82% Tier C (DSHEA Structure/Function (no pre-approval)) ✅ Supported
Nutrient 3% Tier D (Unknown) ✅ Supported
No Claim 2% Tier D (No claim on label) ✅ Supported
Approved Health 0% Tier A (FDA Approved Health Claim (21 CFR 101.9)) ⚠️ Unsupported

🏛️ NIH ODS Factsheet

Research by Topic

⚠️ FDA Safety Data

Research Evidence (178)

Systematic Review: 86 Meta Analysis: 70 Clinical Trial: 10 Rct: 8 Cochrane Review: 2 Openfda Safety: 1
B Treatments of Sexual Dysfunction in Opioid Substitution Therapy Patients: A Systematic Review and Meta-Analysis
Meta Analysis International journal of medical sciences 2021 n=207

**Ramli et al., 2021** | Int J Med Sci | Meta Analysis Ramli Fitri Fareez, Azizi Muhammad Hasif, Syed Hashim Syed Alhafiz. Treatments of Sexual Dysfunction in Opioid Substitution Therapy Patients: A Systematic Review and Meta-Analysis. Int J Med Sci....

B Compound salvia pellet, a traditional Chinese medicine, for the treatment of chronic stable angina pectoris compared with nitrates: a meta-analysis
Meta Analysis Medical science monitor : international medical journal of experimental and clinical research 2006 n=3722

**Wang et al., 2006** | Med Sci Monit | Meta Analysis Wang Gang, Wang Lei, ... Li Ting-Qian. Compound salvia pellet, a traditional Chinese medicine, for the treatment of chronic stable angina pectoris compared with nitrates: a meta-analysis. Med Sci ...

B Efficacy of Ginseng Supplements on Fatigue and Physical Performance: a Meta-analysis
Meta Analysis Journal of Korean medical science 2016 n=630

**Bach et al., 2016** | J Korean Med Sci | Meta Analysis Bach Hoang Viet, Kim Jeongseon, ... Cho Young Ae. Efficacy of Ginseng Supplements on Fatigue and Physical Performance: a Meta-analysis. J Korean Med Sci. 2016-Dec;31(12):1879-1886. doi:10.3346/...

B Dose-response and temporal ergogenic effects of ginseng supplementation in athletes and active participants: A systematic review and meta-analysis
Meta Analysis Journal of sports sciences 2022 n=492

**Khan et al., 2022** | J Sports Sci | Meta Analysis Khan Nasreen, Sharma Saurabh, ... Sharma Raj Kumar. Dose-response and temporal ergogenic effects of ginseng supplementation in athletes and active participants: A systematic review and meta-analysi...

B Clinical efficacy and safety of Panax notoginseng saponins in treating chronic obstructive pulmonary disease with blood hypercoagulability: A meta-analysis of randomized controlled trials
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2024 n=1831

**Zhou et al., 2024** | Phytomedicine | Meta Analysis Zhou Ruiling, Zhang Jie, ... Zhang He. Clinical efficacy and safety of Panax notoginseng saponins in treating chronic obstructive pulmonary disease with blood hypercoagulability: A meta-analysis o...

B [Dan'e-fukang soft extract for dysmenorrhea: a meta-analysis]
Meta Analysis Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 2014 n=1213

**Yu et al., 2014** | Zhejiang Da Xue Xue Bao Yi Xue Ban | Meta Analysis Yu Kun, Zhang Zhen-dong, ... Wang Zheng-long. [Dan'e-fukang soft extract for dysmenorrhea: a meta-analysis]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2014-Jul;43(4):474-9 OBJECTIVE: ...

B Efficacy of ginseng supplements on disease-related fatigue: A systematic review and meta-analysis
Meta Analysis Medicine 2022 n=1298

**Zhu et al., 2022** | Medicine (Baltimore) | Meta Analysis Zhu Jianxun, Xu Xiaoru, ... Wang Zhihong. Efficacy of ginseng supplements on disease-related fatigue: A systematic review and meta-analysis. Medicine (Baltimore). 2022-Jul-01;101(26):e29767....

B The efficacy of ginseng supplementation on plasma lipid concentration in adults: A systematic review and meta-analysis
Meta Analysis Complementary therapies in medicine 2020 n=1245

**Ziaei et al., 2020** | Complement Ther Med | Meta Analysis Ziaei Rahele, Ghavami Abed, ... Clark Cain C T. The efficacy of ginseng supplementation on plasma lipid concentration in adults: A systematic review and meta-analysis. Complement Ther Med. ...

B Effects of select dietary supplements on the prevention and treatment of viral respiratory tract infections: a systematic review of randomized controlled trials
Systematic Review Expert review of respiratory medicine 2021 n=16797

**Shokri-Mashhadi et al., 2021** | Expert Rev Respir Med | Systematic Review Shokri-Mashhadi Nafiseh, Kazemi Maryam, ... Moradi Sajjad. Effects of select dietary supplements on the prevention and treatment of viral respiratory tract infections: a sys...

B Comparative effectiveness of Panax notoginseng saponins-related agents and antiplatelet agents in ischemic stroke: A systematic review and network meta-analysis
Systematic Review Journal of ethnopharmacology 2026 n=18424

**Zhang et al., 2026** | J Ethnopharmacol | Systematic Review Zhang Hongrui, Feng Luda, ... Gao Ying. Comparative effectiveness of Panax notoginseng saponins-related agents and antiplatelet agents in ischemic stroke: A systematic review and network m...

B The effect of ginseng supplementation on CVD risk factors: a comprehensive systematic review and dose-response meta-analysis
Meta Analysis The British journal of nutrition 2025 n=4506

**Jafari et al., 2025** | Br J Nutr | Meta Analysis Jafari Ali, Mardani Helia, ... Alaghi Alireza. The effect of ginseng supplementation on CVD risk factors: a comprehensive systematic review and dose-response meta-analysis. Br J Nutr. 2025-Oct-14;13...

B Sanchi for acute ischaemic stroke.
Cochrane Review The Cochrane database of systematic reviews

BACKGROUND: Currently very few drugs are supported for routine use for acute ischaemic stroke. Sanchi is one of the most widely used herbal medicines for ischaemic stroke in China. OBJECTIVES: To assess the effectiveness and safety of sanchi in the t...

B Ginseng for cognition
Meta Analysis The Cochrane database of systematic reviews 2010

**Geng et al., 2010** | Cochrane Database Syst Rev | Meta Analysis Geng Jinsong, Dong Jiancheng, ... Malouf Reem. Ginseng for cognition. Cochrane Database Syst Rev. 2010-Dec-08(12):CD007769. doi:10.1002/14651858.CD007769.pub2 BACKGROUND: Ginseng is a...

B The Efficacy of Ginseng-Related Therapies in Type 2 Diabetes Mellitus: An Updated Systematic Review and Meta-analysis
Meta Analysis Medicine 2016 n=141

**Gui et al., 2016** | Medicine (Baltimore) | Meta Analysis Gui Qi-Feng, Xu Zhe-Rong, ... Yang Yun-Mei. The Efficacy of Ginseng-Related Therapies in Type 2 Diabetes Mellitus: An Updated Systematic Review and Meta-analysis. Medicine (Baltimore). 2016-...

B Daikenchuto for reducing postoperative ileus in patients undergoing elective abdominal surgery.
Cochrane Review The Cochrane database of systematic reviews

BACKGROUND: Postoperative ileus is a major complication for persons undergoing abdominal surgery. Daikenchuto, a Japanese traditional medicine (Kampo), is a drug that may reduce postoperative ileus. OBJECTIVES: To assess the efficacy and safety of Da...

B Ginseng Consumption Possible Effect on Liver Cancer: A Meta-Analysis
Meta Analysis Nutrition and cancer 2021 n=13766

**Zhu et al., 2021** | Nutr Cancer | Meta Analysis Zhu Chenhong, Wang Jingyi, ... Ren Liping. Ginseng Consumption Possible Effect on Liver Cancer: A Meta-Analysis. Nutr Cancer. 2021;73(9):1581-1589. doi:10.1080/01635581.2020.1803929 INTRODUCTION: Gin...

B Plant Adaptogens-History and Future Perspectives
Meta Analysis Nutrients 2021

**Todorova et al., 2021** | Nutrients | Meta Analysis Todorova Velislava, Ivanov Kalin, ... Ivanova Stanislava. Plant Adaptogens-History and Future Perspectives. Nutrients. 2021-Aug-20;13(8). doi:10.3390/nu13082861 Adaptogens are synthetic compounds ...

B The Efficacy of Ginseng (Panax) on Human Prediabetes and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
Meta Analysis Nutrients 2022

**Naseri et al., 2022** | Nutrients | Meta Analysis Naseri Kaveh, Saadati Saeede, ... Gan Ren-You. The Efficacy of Ginseng (Panax) on Human Prediabetes and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Nutrients. 2022-Jun-09;14(12)...

B The Efficacy of Panax ginseng for the Treatment of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Preclinical Studies
Meta Analysis Nutrients 2023 n=41

**Yang et al., 2023** | Nutrients | Meta Analysis Yang Keungmo, Kim Hee-Hoon, ... Song Myeong Jun. The Efficacy of Panax ginseng for the Treatment of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Preclinical Studies. Nutr...

B Phytochemical Insights into Panax Genus Metabolites: Evidence-Based Fatigue Intervention via Ethnopharmacological and Biomedical Perspectives
Systematic Review The American journal of Chinese medicine 2026 n=105

Traditional Chinese Medicine (TCM) has a longstanding history in the treatment of fatigue-related conditions, and is increasingly recognized as a foundation for novel therapeutic approaches. The Panax genus, extensively utilized in the fundamental TC...

B Complementary and alternative medicine for patients with chronic fatigue syndrome: a systematic review
Systematic Review BMC complementary and alternative medicine 2011 n=3273

**Alraek et al., 2011** | BMC Complement Altern Med | Systematic Review Alraek Terje, Lee Myeong Soo, ... Liu Jianping. Complementary and alternative medicine for patients with chronic fatigue syndrome: a systematic review. BMC Complement Altern Med....

B Ginseng for erectile dysfunction
Meta Analysis The Cochrane database of systematic reviews 2021 n=3

**Lee et al., 2021** | Cochrane Database Syst Rev | Meta Analysis Lee Hye Won, Lee Myeong Soo, ... Moon Du Geon. Ginseng for erectile dysfunction. Cochrane Database Syst Rev. 2021-Apr-19;4(4):CD012654. doi:10.1002/14651858.CD012654.pub2 BACKGROUND: D...

B Management of Fatigue in Adult Survivors of Cancer: ASCO-Society for Integrative Oncology Guideline Update
Systematic Review Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2024 n=113

**Bower et al., 2024** | J Clin Oncol | Systematic Review Bower Julienne E, Lacchetti Christina, ... Mustian Karen. Management of Fatigue in Adult Survivors of Cancer: ASCO-Society for Integrative Oncology Guideline Update. J Clin Oncol. 2024-Jul-10;...

B Ginseng for Cognitive Function in Elderly Adults with Mild Cognitive Impairment, Alzheimer's Disease, or Dementia: A Systematic Review and Meta-Analysis
Meta Analysis Current neuropharmacology 2026 n=617

**Chen et al., 2026** | Curr Neuropharmacol | Meta Analysis Chen Nan, Yu Lirong, ... Li Na. Ginseng for Cognitive Function in Elderly Adults with Mild Cognitive Impairment, Alzheimer's Disease, or Dementia: A Systematic Review and Meta-Analysis. Curr...

B Integrative Medicine for Relief of Nausea and Vomiting in the Treatment of Colorectal Cancer Using Oxaliplatin-Based Chemotherapy: A Systematic Review and Meta-Analysis
Meta Analysis Phytotherapy research : PTR 2016 n=1843

**Chen et al., 2016** | Phytother Res | Meta Analysis Chen Meng Hua, May Brian H, ... Xue Charlie C. Integrative Medicine for Relief of Nausea and Vomiting in the Treatment of Colorectal Cancer Using Oxaliplatin-Based Chemotherapy: A Systematic Revie...

B Panax ginseng clinical trials: Current status and future perspectives
Systematic Review Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2020 n=200

**Fan et al., 2020** | Biomed Pharmacother | Systematic Review Fan Shasha, Zhang Zepeng, ... Li Xiangyan. Panax ginseng clinical trials: Current status and future perspectives. Biomed Pharmacother. 2020-Dec;132:110832. doi:10.1016/j.biopha.2020.11083...

B Beneficial effects of natural products on female sexual dysfunction: A systematic review and meta-analysis
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2021 n=536

**Sha'ari et al., 2021** | Phytomedicine | Meta Analysis Sha'ari Nahdiya, Woon Luke Sy-Cherng, ... Mohamed Saini Suriati. Beneficial effects of natural products on female sexual dysfunction: A systematic review and meta-analysis. Phytomedicine. 2021-...

B Exploratory Systematic Review and Meta-Analysis of Panax Genus Plant Ingestion Evaluation in Exercise Endurance
Meta Analysis Nutrients 2022

**Ikeuchi et al., 2022** | Nutrients | Meta Analysis Ikeuchi Shingo, Minamida Mika, ... Kamioka Hiroharu. Exploratory Systematic Review and Meta-Analysis of Panax Genus Plant Ingestion Evaluation in Exercise Endurance. Nutrients. 2022-Mar-11;14(6). d...

B Systematic evaluation of combined herbal adjuvant therapy for proliferative diabetic retinopathy
Meta Analysis Frontiers in endocrinology 2023 n=1392

**Huai et al., 2023** | Front Endocrinol (Lausanne) | Meta Analysis Huai Baogeng, Huai Baosha, ... Liu Deshan. Systematic evaluation of combined herbal adjuvant therapy for proliferative diabetic retinopathy. Front Endocrinol (Lausanne). 2023;14:1157...

B The use of Panax notoginseng saponins injections after intravenous thrombolysis in acute ischemic stroke: a systematic review and meta-analysis
Systematic Review Frontiers in pharmacology 2024 n=1856

**Liu et al., 2024** | Front Pharmacol | Systematic Review Liu Yaoyuan, Niu Puyu, ... Pang Wentai. The use of Panax notoginseng saponins injections after intravenous thrombolysis in acute ischemic stroke: a systematic review and meta-analysis. Front ...

B Effects of Ginseng on Cognitive Function: A Systematic Review and Meta-Analysis
Meta Analysis Phytotherapy research : PTR 2024 n=671

Ginseng is a kind of traditional Chinese medicine. It is widely believed that ginseng can improve cognitive function, but its clinical efficacy is still controversial. This study aimed to systematically evaluate the effects of ginseng on cognitive fu...

B Efficacy and safety of commercial Chinese polyherbal preparation combined with oxaliplatin-based chemotherapy for gastric cancer: a systematic review and network meta-analysis
Systematic Review Frontiers in pharmacology 2025 n=15320

**Pan et al., 2025** | Front Pharmacol | Systematic Review Pan Bei, Lai Honghao, ... Yang Kehu. Efficacy and safety of commercial Chinese polyherbal preparation combined with oxaliplatin-based chemotherapy for gastric cancer: a systematic review and ...

B A traditional herbal medication, Maekmoondong-tang, for cough: A systematic review and meta-analysis
Meta Analysis Journal of ethnopharmacology 2016 n=1145

**Kim et al., 2016** | J Ethnopharmacol | Meta Analysis Kim Kwan-Il, Shin Seungwon, ... Lee Hyangsook. A traditional herbal medication, Maekmoondong-tang, for cough: A systematic review and meta-analysis. J Ethnopharmacol. 2016-Feb-03;178:144-54. doi...

B The effect of ginseng (genus Panax) on blood pressure: a systematic review and meta-analysis of randomized controlled clinical trials
Meta Analysis Journal of human hypertension 2016 n=1381

**Komishon et al., 2016** | J Hum Hypertens | Meta Analysis Komishon A M, Shishtar E, ... Vuksan V. The effect of ginseng (genus Panax) on blood pressure: a systematic review and meta-analysis of randomized controlled clinical trials. J Hum Hypertens...

B A Chinese patent medicine, Shexiang Baoxin Pill, for Non-ST-elevation acute coronary syndromes: A systematic review
Meta Analysis Journal of ethnopharmacology 2016 n=1389

**Zhou et al., 2016** | J Ethnopharmacol | Meta Analysis Zhou Zhou, Shen Weixing, ... Wu Qibiao. A Chinese patent medicine, Shexiang Baoxin Pill, for Non-ST-elevation acute coronary syndromes: A systematic review. J Ethnopharmacol. 2016-Dec-24;194:11...

B Panax notoginseng Preparations for Unstable Angina Pectoris: A Systematic Review and Meta-Analysis
Meta Analysis Phytotherapy research : PTR 2017 n=1828

**Song et al., 2017** | Phytother Res | Meta Analysis Song Haiying, Wang Peili, ... Wang Chenglong. Panax notoginseng Preparations for Unstable Angina Pectoris: A Systematic Review and Meta-Analysis. Phytother Res. 2017-Aug;31(8):1162-1172. doi:10.10...

B Panax notoginseng preparations as adjuvant therapy for diabetic kidney disease: a systematic review and meta-analysis
Meta Analysis Pharmaceutical biology 2020 n=1918

**Tang et al., 2020** | Pharm Biol | Meta Analysis Tang Xiuge, Huang Mingdi, ... Li Yan. Panax notoginseng preparations as adjuvant therapy for diabetic kidney disease: a systematic review and meta-analysis. Pharm Biol. 2020-Dec;58(1):138-145. doi:10...

B Dietary Supplements for Erectile Dysfunction: Analysis of Marketed Products, Systematic Review, Meta-Analysis and Rational Use
Meta Analysis Nutrients 2023

**Petre et al., 2023** | Nutrients | Meta Analysis Petre Gabriel Cosmin, Francini-Pesenti Francesco, ... Garolla Andrea. Dietary Supplements for Erectile Dysfunction: Analysis of Marketed Products, Systematic Review, Meta-Analysis and Rational Use. N...

B Efficacy and safety of herbal medicines intervention for cachexia associated with cancer: A systematic review and meta-analysis
Meta Analysis Phytotherapy research : PTR 2023 n=3654

**Chen et al., 2023** | Phytother Res | Meta Analysis Chen Guoming, Wang Ning, ... Feng Yibin. Efficacy and safety of herbal medicines intervention for cachexia associated with cancer: A systematic review and meta-analysis. Phytother Res. 2023-Nov;37...

B Lysophosphatidic Acid (LPA) and Its Receptors in Mood Regulation: A Systematic Review of the Molecular Mechanisms and Therapeutic Potential
Systematic Review International journal of molecular sciences 2024

**Li et al., 2024** | Int J Mol Sci | Systematic Review Li Nan, Li Yanchun. Lysophosphatidic Acid (LPA) and Its Receptors in Mood Regulation: A Systematic Review of the Molecular Mechanisms and Therapeutic Potential. Int J Mol Sci. 2024-Jul-06;25(13)...

B Cognitive Benefits of Ginseng: A Systematic Review and Meta-Analysis of Changes in Mini-Mental State Examination and Alzheimer's Disease Assessment Scale-Cognitive Subscale Scores
Meta Analysis Complementary medicine research 2025

**Kim et al., 2025** | Complement Med Res | Meta Analysis Kim Junyeon, Kang Minji, Lim Hyunjung. Cognitive Benefits of Ginseng: A Systematic Review and Meta-Analysis of Changes in Mini-Mental State Examination and Alzheimer's Disease Assessment Scale...

B Traditional Chinese Medicines in the treatment of hepatocellular cancers: a systematic review and meta-analysis
Meta Analysis Journal of experimental & clinical cancer research : CR 2009 n=3236

**Wu et al., 2009** | J Exp Clin Cancer Res | Meta Analysis Wu Ping, Dugoua Jean Jacques, ... Mills Edward J. Traditional Chinese Medicines in the treatment of hepatocellular cancers: a systematic review and meta-analysis. J Exp Clin Cancer Res. 2009...

B Oral ginseng formulae for stable chronic obstructive pulmonary disease: a systematic review
Systematic Review Respiratory medicine 2011 n=1560

**An et al., 2011** | Respir Med | Systematic Review An Xuedong, Zhang Anthony Lin, ... Xue Charlie Changli. Oral ginseng formulae for stable chronic obstructive pulmonary disease: a systematic review. Respir Med. 2011-Feb;105(2):165-76. doi:10.1016/...

B Red ginseng for type 2 diabetes mellitus: a systematic review of randomized controlled trials
Meta Analysis Chinese journal of integrative medicine 2011 n=76

**Kim et al., 2011** | Chin J Integr Med | Meta Analysis Kim Sina, Shin Byung-Cheul, ... Ernst Edzard. Red ginseng for type 2 diabetes mellitus: a systematic review of randomized controlled trials. Chin J Integr Med. 2011-Dec;17(12):937-44. doi:10.10...

B Medicinal Plants and Their Impact on the Gut Microbiome in Mental Health: A Systematic Review
Systematic Review Nutrients 2022

**Pferschy-Wenzig et al., 2022** | Nutrients | Systematic Review Pferschy-Wenzig Eva-Maria, Pausan Manuela R, ... Bauer Rudolf. Medicinal Plants and Their Impact on the Gut Microbiome in Mental Health: A Systematic Review. Nutrients. 2022-May-18;14(1...

B Ginseng-containing traditional medicine preparations in combination with fluoropyrimidine-based chemotherapy for advanced gastric cancer: A systematic review and meta-analysis
Meta Analysis PloS one 2023 n=1960

**Hu et al., 2023** | PLoS One | Meta Analysis Hu Jiaqi, Cheng Mengqi, ... Liu Rui. Ginseng-containing traditional medicine preparations in combination with fluoropyrimidine-based chemotherapy for advanced gastric cancer: A systematic review and meta...

B The efficacy and safety of Chinese herbal medicine for mild cognitive impairment: a systematic review and meta-analysis of randomized placebo-controlled trials
Systematic Review Frontiers in pharmacology 2024 n=1043

**Liu et al., 2024** | Front Pharmacol | Systematic Review Liu Lingling, Zhang Claire Shuiqing, ... Xue Charlie Changli. The efficacy and safety of Chinese herbal medicine for mild cognitive impairment: a systematic review and meta-analysis of random...

B Efficacy and safety of Panax notoginseng saponin injection in the treatment of acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials
Systematic Review Frontiers in pharmacology 2024 n=1881

**Chen et al., 2024** | Front Pharmacol | Systematic Review Chen Pengfei, Gao Zhuye, ... Shi Dazhuo. Efficacy and safety of Panax notoginseng saponin injection in the treatment of acute myocardial infarction: a systematic review and meta-analysis of ...

B Red ginseng for treating erectile dysfunction: a systematic review
Meta Analysis British journal of clinical pharmacology 2008 n=349

**Jang et al., 2008** | Br J Clin Pharmacol | Meta Analysis Jang Dai-Ja, Lee Myeong Soo, ... Ernst Edzard. Red ginseng for treating erectile dysfunction: a systematic review. Br J Clin Pharmacol. 2008-Oct;66(4):444-50. doi:10.1111/j.1365-2125.2008.03...

B An Analysis of Popular Online Erectile Dysfunction Supplements
Systematic Review The journal of sexual medicine 2019 n=413

**Balasubramanian et al., 2019** | J Sex Med | Systematic Review Balasubramanian Adithya, Thirumavalavan Nannan, ... Pastuszak Alexander W. An Analysis of Popular Online Erectile Dysfunction Supplements. J Sex Med. 2019-Jun;16(6):843-852. doi:10.1016...

Showing top 50 of 178 sources, sorted by quality score.

Related Supplements

Frequently Asked Questions

What is ginseng and what are its main benefits?

Ginseng is a widely researched supplement primarily used to support physical performance, fatigue reduction, and metabolic health. There is strong evidence for its use in improving performance and moderate evidence regarding its impact on cognitive and cardiovascular health.

Does ginseng help with fatigue and energy levels?

Yes, there is strong evidence that ginseng supplements are effective in improving physical performance and reducing both general and disease-related fatigue. This makes it a highly researched option for those seeking energy support.

Can ginseng help manage Type 2 Diabetes?

There is moderate evidence suggesting that ginseng-related therapies can be effective in the management of Type 2 Diabetes Mellitus. However, you should always consult a medical professional before using supplements to manage blood sugar.

Is ginseng good for brain function and memory?

There is moderate evidence, including Cochrane reviews, suggesting that ginseng may be effective for cognitive enhancement. It is often studied for its potential to improve mental clarity and cognitive performance.

Can ginseng support heart health?

There is moderate evidence indicating that ginseng supplementation may influence plasma lipid concentrations and various cardiovascular disease risk factors. This suggests a potential role in supporting overall cardiovascular health.

Are there any known drug interactions or safety concerns with ginseng?

No specific drug interactions or contraindications have been documented in the provided research. However, you should always consult a healthcare provider before starting ginseng to ensure it is safe for your specific health profile.

What is the recommended dose of ginseng?

The available research does not provide an explicitly defined effective dose range for ginseng. You should work with a healthcare professional to determine the appropriate dosage for your individual needs.

Answers generated from research evidence. Not medical advice.